Insmed reports fourth quarter and full year 2021 financial results and provides business and pipeline update

Bridgewater, n.j., feb. 17, 2022 /prnewswire/ -- insmed incorporated (nasdaq:insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the fourth quarter and full year ended december 31, 2021 and provided an update on the company's business and pipeline.
INSM Ratings Summary
INSM Quant Ranking